Private Equity

Updated:

Surrey Capital Partners

Surrey Capital Partners is a venture capital firm founded in 2019 in New York, New York. It focuses on the life sciences industry, investing in early to...

Surrey Capital Partners

Surrey Capital Partners is a venture capital firm founded in 2019 in New York, New York. It focuses on the life sciences industry, investing in early to mid-stage biotech and healthcare companies. The firm has made 2 investments, including a Seed VC investment in AiM Medical Robotics on May 01, 2021.

General information

Firm type

Private Equity

Year founded

2019

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Frequently asked questions

What investment stages does Surrey Capital Partners target?

Surrey Capital Partners' strategy spans early-stage seed and startup rounds through expansion and late-stage venture, per structured research records. This full-lifecycle approach suggests the firm can support portfolio companies from initial formation through growth equity. No specific check-size range or revenue threshold is publicly disclosed.

Why does Surrey Capital Partners maintain such a low public profile?

The firm's absence from public websites, LinkedIn, and institutional disclosures points to a deliberate low-profile operating model. Managers adopting this posture typically rely on existing LP relationships and referrals rather than broad marketing, and may prefer to keep portfolio construction and competitive positioning opaque to rivals. This approach is common among firms that raise capital from family offices and high-net-worth individuals who value discretion.

Is Surrey Capital Partners structured as a family office or a traditional private equity firm?

Surrey Capital Partners is categorized as an asset manager with a private equity strategy, not a single-family or multi-family office. The firm deploys third-party capital into venture and expansion-stage companies. No affiliation with a specific family wealth origin is disclosed in public records.

Does Surrey Capital Partners participate in fund commitments or only direct deals?

Available records do not specify whether the firm makes direct investments, fund commitments, or co-investments. The firm's strategy description — covering seed through late-stage venture — is compatible with both direct and fund-of-funds models. Without a named portfolio or track record, the exact deployment structure remains unconfirmed.

Who runs investment decisions at Surrey Capital Partners?

No founding partners, CIOs, or managing principals are named in public datasets or the firm's own sparse online footprint as of mid-2026. Decision-makers may operate behind a structured veil, which is not unusual for small, relationship-driven managers. Identifying the key principals would require direct outreach or network-based intelligence.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles